Journey Medical Corp
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Show More...
-
Website https://journeymedicalcorp.com
-
Sector Healthcare
-
Industry Drug Manufacturers-Specialty & Generic
-
Last Quote 8.06 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
1988-12 1989-12 1990-12 1991-12 1992-12 1993-12 1994-12 1995-12 1996-12 1997-12 TTM Earnings Per Share USD -0.75 -4.61 -0.71 -0.7 -1.05 -1.59 -1.41 Dividends USD Payout Ratio % * Shares Mil 5.0 7.0 7.0 7.0 7.0 8.0 8.0 Book Value Per Share * USD 3.76 3.19 2.32 1.18 0.64 Free Cash Flow Per Share * USD -0.75 -0.73 -2.48 -1.13 -1.26 Return on Assets % -38.54 -29.65 -19.61 -24.1 -52.96 -121.53 -74.92 Financial Leverage (Average) 1.1 1.05 1.14 1.13 1.24 1.96 1.97 Return on Equity % -42.53 -31.52 -21.32 -27.32 -62.04 -184.06 -107.48 Return on Invested Capital % -41.57 -31.16 -21.23 -27.17 -62.04 -184.06 -107.48 Interest Coverage Current Ratio 11.38 21.0 7.18 7.55 3.71 1.52 1.78 Quick Ratio 11.0 20.42 6.79 4.8 1.61 0.52 1.25 Debt/Equity 0.010 0.010